These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7843635)

  • 1. Current concepts in coronary thrombolysis.
    Grignani G; Zucchella M; Brocchieri A; Saporiti A
    Haematologica; 1994; 79(5):475-82. PubMed ID: 7843635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of new thrombolytic substances].
    Zeymer U; Neuhaus KL
    Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Different therapeutic regimens in thrombolysis of acute myocardial infarct].
    Zeymer U; Neuhaus KL
    Z Kardiol; 1994; 83 Suppl 6():83-8. PubMed ID: 7863705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics.
    Bell WR
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S34-44. PubMed ID: 12556741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D; Lijnen HR
    Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombolytic therapy of acute myocardial infarct--current status and new developments].
    Bode C; Schuler G; von Hodenberg E; Nordt T; Kübler W
    Z Gesamte Inn Med; 1993; 48(6-7):304-15. PubMed ID: 8333227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The fibrinolytic system and its activators].
    Seifried E
    Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
    Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
    Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
    De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG
    Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Strategies to improve reperfusion with fibrinolytic therapy in ST-T elevation myocardial infarction].
    Jerjes-Sánchez C; Sosa del Angel E; García Sosa A; Reyes Cerezo E; Garza Ruiz A
    Arch Cardiol Mex; 2003; 73(1):46-58. PubMed ID: 12820494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of systemic arterial hypertension on mid-term survival of patients with acute myocardial infarction treated with fibrinolytic agents].
    Martínez Sande JL; González-Juanatey JR; García-Acuña JM; Amaro Cendón A; Fernández Vázquez F; Fernández López JA; García Seara J; Vega Fernández JM; López Lago A; Gil de la Peña M
    Med Clin (Barc); 1997 Oct; 109(14):532-7. PubMed ID: 9580043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic agents--an overview.
    Gulba DC; Bode C; Runge MS; Huber K
    Ann Hematol; 1996; 73 Suppl 1():S9-27. PubMed ID: 8853112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does streptokinase still have a role in the treatment of acute myocardial infarct?].
    Janousek S
    Vnitr Lek; 2003 Nov; 49(11):880-4. PubMed ID: 14689685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
    Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
    Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrinolysis in myocardial infarction with EKG elevation. Optimization of myocardial reperfusion by treatment with antithrombotic agents].
    Jaïs C; Coste P; Labèque JN; Perron JM; Lafitte S; Zabsonré P; Roudaut R
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1259-66. PubMed ID: 11794967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of the kinin system as an alternative method of prevention or reduction reperfusive damages within thrombolytic therapy in patients with acute myocardium infarction.
    Korotkov A; Kistauri A; Korotkova A; Jibladze M; Guchua E
    Georgian Med News; 2006 Nov; (140):54-62. PubMed ID: 17179590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of thrombolytic therapy on recanalization in different starting time of treatment after acute myocardial infarction.
    Shen L; Yang J; Hu Q; Teng Y; Han X; Yan S; Lian M; Xie M; Gu F
    Chin Med J (Engl); 1997 Jan; 110(1):53-5. PubMed ID: 9594323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.